1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Epetraborole: new trials by email Literature Review of Epetraborole trials Research Report on Epetraborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease Epetraborole, Placebo - MAC Lung Disease, Treatment Refractory MAC Lung Disease | Phase 2 / Phase 3 | Terminated | AN2 Therapeutics, Inc | 177 | 2022-05-20 | 2026-06-10 |
Infections (1) · Mycobacterium Infections (1) · Mycobacterium avium-intracellulare Infection (1) · Respiratory Tract Infections (1)
Australia (1) · Japan (1) · South Korea (1) · United States (1)